arrow

From NeuroLex

Jump to: navigation, search
Category:Dorzolamide
Comment taken from DrugBank
Curator Ab +
DefiningCitation http://www.drugbank.ca/drugs/DB00869  +
Definition Dorzolamide is a carbonic anhydrase inhibi Dorzolamide is a carbonic anhydrase inhibitor. It is used in ophthalmic solutions (Trusopt) to lower increased intraocular pressure in open-angle glaucoma and ocular hypertension. Pharmacology: Dorzolamide is topical carbonic anhydrase inhibitor. Dorzolamide is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers. Mechanism of action: Dorzolamide is a sulfonamide and a human carbonic anhydrase II inhibitor. Inhibition of carbonic anhydrase II in the ciliary processes of the eye decreases aqueous humor secretion, presumably by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport. Drug type: Approved. Small Molecule. Drug category: Antihypertensive Agents. Carbonic Anhydrase Inhibitors sive Agents. Carbonic Anhydrase Inhibitors
Has role Drug +
Id DB00869  +
Label Dorzolamide  +
Modification dateThis property is a special property in this wiki. 14 April 2014 20:17:43  +
ModifiedDate 14 April 2014  +
RelatedTo Carbonic anhydrase 2 +
SuperCategory Molecular entity  +
Synonym Trusopt  +
Categories Molecular entity
hide properties that link here 
  No properties link to this page.
 

 

Enter the name of the page to start browsing from.

*Note: Neurolex imports many terms and their ids from existing community ontologies, e.g., the Gene Ontology. Neurolex, however, is a dynamic site and any content beyond the identifier should not be presumed to reflect the content or views of the source ontology. Users should consult with the authoritative source for each ontology for current information.